Enzyme-alterable alkylating agents. II. Clinical evaluation of N, N′-bis[(2-chloroethylthio)acetyl]-1,2-ethylenediamine (S-46)
Louis E. Goodman; Stanley P. Kramer; Samuel D. Gaby; Daniel Bakal; Robert D. Solomon; Charles E. Williamson; Jacob I. Miller; Samuel Sass; Benjamin Witten; Arnold M. Seligman
- 作者Louis E. Goodman; Stanley P. Kramer; Samuel D. Gaby; Daniel Bakal; Robert D. Solomon; Charles E. Williamson; Jacob I. Miller; Samuel Sass; Benjamin Witten; Arnold M. Seligman
- 卷第15卷
- 期第5期
- 印刷ISSN0008-543X
- 电子ISSN1097-0142
- 文件大小591.72KB
- 发表时间1962
- DOI10.1002/1097-0142(196209/10)15:5<1056::aid-cncr2820150522>3.0.co;2-u
- 页码1056-1061